rabbit anti cd3 Search Results


85
Boster Bio rabbit anti cd3
Rabbit Anti Cd3, supplied by Boster Bio, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti cd3/product/Boster Bio
Average 85 stars, based on 1 article reviews
rabbit anti cd3 - by Bioz Stars, 2026-03
85/100 stars
  Buy from Supplier

90
Fisher Scientific rabbit monoclonal anti- mouse cd3 clone: ma5-14524
Rabbit Monoclonal Anti Mouse Cd3 Clone: Ma5 14524, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit monoclonal anti- mouse cd3 clone: ma5-14524/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
rabbit monoclonal anti- mouse cd3 clone: ma5-14524 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Marque cd3 (rabbit anti-human
Cd3 (Rabbit Anti Human, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd3 (rabbit anti-human/product/Cell Marque
Average 90 stars, based on 1 article reviews
cd3 (rabbit anti-human - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Novocastra anti-cd3
Anti Cd3, supplied by Novocastra, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd3/product/Novocastra
Average 90 stars, based on 1 article reviews
anti-cd3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
IonPath Inc rabbit anti-human cd3 mrq-39
Rabbit Anti Human Cd3 Mrq 39, supplied by IonPath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-human cd3 mrq-39/product/IonPath Inc
Average 90 stars, based on 1 article reviews
rabbit anti-human cd3 mrq-39 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cell Marque polyclonal rabbit anti-murine cd3 antibody cmc10317022
Polyclonal Rabbit Anti Murine Cd3 Antibody Cmc10317022, supplied by Cell Marque, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti-murine cd3 antibody cmc10317022/product/Cell Marque
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-murine cd3 antibody cmc10317022 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Genemed Biotechnologies rabbit anti-cd3
Rabbit Anti Cd3, supplied by Genemed Biotechnologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-cd3/product/Genemed Biotechnologies
Average 90 stars, based on 1 article reviews
rabbit anti-cd3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Fisher Scientific rabbit anti-human cd3 rm9107s0
Rabbit Anti Human Cd3 Rm9107s0, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-human cd3 rm9107s0/product/Fisher Scientific
Average 90 stars, based on 1 article reviews
rabbit anti-human cd3 rm9107s0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Fuzhou Maxim Biotech rabbit anti-human cd3 monoclonal antibody
Rabbit Anti Human Cd3 Monoclonal Antibody, supplied by Fuzhou Maxim Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-human cd3 monoclonal antibody/product/Fuzhou Maxim Biotech
Average 90 stars, based on 1 article reviews
rabbit anti-human cd3 monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Nichirei Biosciences rabbit anti-mouse cd3 (sp7) monoclonal antibody
Rabbit Anti Mouse Cd3 (Sp7) Monoclonal Antibody, supplied by Nichirei Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse cd3 (sp7) monoclonal antibody/product/Nichirei Biosciences
Average 90 stars, based on 1 article reviews
rabbit anti-mouse cd3 (sp7) monoclonal antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Becton Dickinson rabbit anti-human cd3
Rabbit Anti Human Cd3, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-human cd3/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
rabbit anti-human cd3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ZSGB Biotech rabbit anti- human cd3 antibody ep41
Miltefosine enhances CAR-T cell efficacy against solid tumors in vivo (A) Experimental timeline of CDX model and the fold change of tumor volume in CAR-T cell-treated CDX mouse model in the presence or absence of miltefosine administration (PBS group, n = 3; other groups, n = 5). (B) Tumor weight of each group at the end of experiment (PBS group, n = 3; other groups, n = 5). (C) The percentages of mesothelin- and <t>hCD3-positive</t> area in tumor tissues (PBS group, n = 2; other groups, n = 5). Scale bar: 200 μm. (D) The fold change of tumor volume in CDX mouse model treated with CAR-T cells derived from another donor, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (E) The proportion of hCD3 + T cells in the peripheral blood of CDX mouse model ( n = 4). (F) The fold change of tumor volume in CAR-T cell-treated PDX mouse model, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (G) The proportion of hCD3 + T cells in the peripheral blood of PDX mouse model ( n = 4). Unpaired t test was used in statistical analysis. (H) Experimental timeline of the OT-1-treated melanoma isograft tumor model. (I) The fold change in tumor volume in the OT-1-treated melanoma isograft tumor model in the presence or absence of miltefosine administration ( n = 7). Unpaired t test was used in statistical analysis. NS, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. All error bars denote SEM. See also <xref ref-type=Figure S7 . " width="250" height="auto" />
Rabbit Anti Human Cd3 Antibody Ep41, supplied by ZSGB Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti- human cd3 antibody ep41/product/ZSGB Biotech
Average 90 stars, based on 1 article reviews
rabbit anti- human cd3 antibody ep41 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Miltefosine enhances CAR-T cell efficacy against solid tumors in vivo (A) Experimental timeline of CDX model and the fold change of tumor volume in CAR-T cell-treated CDX mouse model in the presence or absence of miltefosine administration (PBS group, n = 3; other groups, n = 5). (B) Tumor weight of each group at the end of experiment (PBS group, n = 3; other groups, n = 5). (C) The percentages of mesothelin- and hCD3-positive area in tumor tissues (PBS group, n = 2; other groups, n = 5). Scale bar: 200 μm. (D) The fold change of tumor volume in CDX mouse model treated with CAR-T cells derived from another donor, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (E) The proportion of hCD3 + T cells in the peripheral blood of CDX mouse model ( n = 4). (F) The fold change of tumor volume in CAR-T cell-treated PDX mouse model, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (G) The proportion of hCD3 + T cells in the peripheral blood of PDX mouse model ( n = 4). Unpaired t test was used in statistical analysis. (H) Experimental timeline of the OT-1-treated melanoma isograft tumor model. (I) The fold change in tumor volume in the OT-1-treated melanoma isograft tumor model in the presence or absence of miltefosine administration ( n = 7). Unpaired t test was used in statistical analysis. NS, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. All error bars denote SEM. See also <xref ref-type=Figure S7 . " width="100%" height="100%">

Journal: Cell Reports Medicine

Article Title: Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state

doi: 10.1016/j.xcrm.2024.101869

Figure Lengend Snippet: Miltefosine enhances CAR-T cell efficacy against solid tumors in vivo (A) Experimental timeline of CDX model and the fold change of tumor volume in CAR-T cell-treated CDX mouse model in the presence or absence of miltefosine administration (PBS group, n = 3; other groups, n = 5). (B) Tumor weight of each group at the end of experiment (PBS group, n = 3; other groups, n = 5). (C) The percentages of mesothelin- and hCD3-positive area in tumor tissues (PBS group, n = 2; other groups, n = 5). Scale bar: 200 μm. (D) The fold change of tumor volume in CDX mouse model treated with CAR-T cells derived from another donor, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (E) The proportion of hCD3 + T cells in the peripheral blood of CDX mouse model ( n = 4). (F) The fold change of tumor volume in CAR-T cell-treated PDX mouse model, in the presence or absence of miltefosine or anti-PD-1 antibody treatment ( n = 4). (G) The proportion of hCD3 + T cells in the peripheral blood of PDX mouse model ( n = 4). Unpaired t test was used in statistical analysis. (H) Experimental timeline of the OT-1-treated melanoma isograft tumor model. (I) The fold change in tumor volume in the OT-1-treated melanoma isograft tumor model in the presence or absence of miltefosine administration ( n = 7). Unpaired t test was used in statistical analysis. NS, not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. All error bars denote SEM. See also Figure S7 .

Article Snippet: Rabbit anti- human CD3 Antibody (clone EP41) , ZSGB-BIO , Cat#ZA-0503.

Techniques: In Vivo, Derivative Assay

Journal: Cell Reports Medicine

Article Title: Miltefosine reinvigorates exhausted T cells by targeting their bioenergetic state

doi: 10.1016/j.xcrm.2024.101869

Figure Lengend Snippet:

Article Snippet: Rabbit anti- human CD3 Antibody (clone EP41) , ZSGB-BIO , Cat#ZA-0503.

Techniques: Functional Assay, Flow Cytometry, Control, Recombinant, Lysis, Activation Assay, Transfection, Luciferase, Viability Assay, SYBR Green Assay, RNA Sequencing Assay, Construct, Plasmid Preparation, Software